BioTime, Inc.
BioTime Announces Stem Cell Co-marketing Agreement with Millipore
Published in Surgery Litigation and Law Weekly, July 24th, 2009
BioTime, Inc. (OTCBB:BTIM) announced that Millipore Corporation and BioTime's subsidiary Embryome Sciences, Inc., have entered into a co-marketing agreement whereby Millipore will become a worldwide distributor of ACTCellerate™ human progenitor cell lines. Derived from human embryonic stem cells but not fully differentiated into specific cell types, each ACTCellerate™ line provides a convenient, highly purified source of progenitor cells that may have applications in drug discovery, research, and the development of therapeutic products.
"The Millipore team is committed to supplying high quality products to transport the emerging field of regenerative medicine to an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Breast Cancer Screening
New breast cancer screening study results reported from University of Washington, Medical Department - Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board - Medicare and Medicaid
National Survey: Americans Fear Paying for Cancer Treatment As Much As Dying of the Disease - Merck & Co., Inc.
Merck & Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease - Abbott
Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal Vet, a New Chemotherapeutic Agent for Dogs - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm research from Federal University discussed - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
